IkappaB
proteins play an important role in regulating
NF-kappaB induction following a diverse range of environmental
injuries. Studies evaluating
IkappaBbeta knock-in mice (AKBI), in which the
IkappaBalpha gene is replaced by the
IkappaBbeta cDNA, have uncovered divergent properties of
IkappaBalpha and
IkappaBbeta that influence their ability to activate hepatic
NF-kappaB and subsequent downstream proinflammatory processes in a stimulus-specific manner. While AKBI mice demonstrated identical levels of hepatic
NF-kappaB activation in response to
endotoxin, a significantly reduced level of hepatic
NF-kappaB activation was observed in AKBI mice after liver
ischemia/reperfusion (I/R) injury. This reduced level of
NF-kappaB activation in AKBI mice after liver I/R also correlated with decreased induction of serum
TNF-alpha, reduced hepatic
inflammation, and increased survival. In contrast, no differences in any of these indicators were observed between AKBI mice and WT littermates after a lethal injection of LPS. Molecular studies suggest that the specificity of
IkappaBalpha, but not
IkappaBbeta, to properly regulate
NF-kappaB induction during the acute phase of I/R injury is due to injury context-specific activation of c-Src and subsequent
tyrosine phosphorylation of
IkappaBalpha on Tyr42. These results demonstrate that
IkappaBalpha and
IkappaBbeta play unique injury context-specific roles in activating
NF-kappaB-mediated proinflammatory responses and suggest that strategies aimed at inhibiting
IkappaBalpha gene expression may be of potential therapeutic benefit in hepatic I/R injury.